Archive
Proactive news snapshot: Rockfire Resources, SkinBioTherapeutics, 88 Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
LON:SBTX
SkinBioTherapeutics PLC is a life science company focused on skin health. The company’s proprietary platform technology, SkinBiotix ® , is based upon discoveries made at The University of Manchester.
156 stories · page 6 of 8
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Companies covered today include 88 Energy, Bagir Group, Future, Mpac, NAHL, Quadrise Fuels and Smiths Group
“Ethics approval is a prerequisite for human clinical trials and therefore required before our human study can commence”
Investments and investor services
The index of leading UK shares closed up just shy of 50 points higher at 7,676, while the FTSE 250 was also up
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A look at today's major risers and fallers in London, including Advanced Oncotherapy, Tekcapital, IDOX, RedstoneConnect, Dixons Carphone and Renold
The AIM-listed skin health company said the £600,000 grant would provide funding to investigate how ageing affects the skin and in particular, its microbiome
In the current markets, the pound fell 0.49% against the US dollar at 1.1472..
The reporting period saw the company sign a number of commercial deals of increasing value across its product range as it builds multiple revenue streams from manufacturing, application and distribution partners across the world
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
A look at some of the top risers and fallers in London on Monday
The AIM-listed skin health company said the application covered the use of its SkinBiotix technology for increasing filaggrin levels in the skin
FTSE 250 fared better though closing ahead by around 15 points at 20,800.
With 120 women taking part, the study is double the original size
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Some of the top news-driven risers in London at 3.45pm ...